HEART FAILURE REVIEWS
Scope & Guideline
Transforming Heart Failure Understanding Through Collaboration
Introduction
Aims and Scopes
- Clinical Management of Heart Failure:
The journal emphasizes the importance of clinical management strategies for heart failure, including pharmacological treatments, lifestyle interventions, and the use of advanced therapies such as device management and surgical options. - Innovative Therapeutic Approaches:
Research published in the journal often explores novel therapeutic approaches, such as the use of SGLT2 inhibitors, GLP-1 receptor agonists, and other emerging drugs, highlighting their efficacy and mechanisms in heart failure management. - Diagnosis and Prognosis:
The journal focuses on advancements in diagnostic techniques, including echocardiography, cardiac MRI, and biomarkers, as well as prognostic tools that aid in assessing heart failure severity and outcomes. - Pathophysiology and Mechanisms:
A significant portion of the articles delve into the underlying mechanisms and pathophysiology of heart failure, including molecular, genetic, and inflammatory aspects that contribute to disease progression. - Comorbidities and Multidisciplinary Care:
The journal promotes the understanding of comorbid conditions associated with heart failure, advocating for a multidisciplinary approach to patient care that addresses both cardiac and non-cardiac issues.
Trending and Emerging
- Digital Health and Telemonitoring:
The integration of digital health technologies and telemonitoring for heart failure management is increasingly highlighted, showcasing the potential for improving patient outcomes through remote monitoring and engagement. - Heart Failure with Preserved Ejection Fraction (HFpEF):
Research on HFpEF is gaining traction, with a focus on its unique challenges, therapeutic options, and the development of specific management guidelines, reflecting a better understanding of this complex condition. - Personalized and Precision Medicine:
There is a growing trend towards personalized medicine in heart failure treatment, with an emphasis on tailoring therapies based on genetic, molecular, and phenotypic characteristics of patients. - Innovative Biomarkers and Diagnostic Tools:
The exploration of novel biomarkers and advanced diagnostic tools, such as cardiac imaging techniques and machine learning algorithms, is becoming more prevalent, enhancing the ability to stratify risk and personalize treatment. - Impact of Lifestyle Modifications:
Recent publications increasingly emphasize the significance of lifestyle modifications, including dietary and exercise interventions, as integral components of heart failure management.
Declining or Waning
- Traditional Pharmacological Approaches:
There seems to be a decreasing emphasis on traditional pharmacological treatments such as ACE inhibitors and beta-blockers, as newer therapies like SGLT2 inhibitors gain prominence in heart failure management. - Isolated Studies on Specific Comorbidities:
Research focusing solely on specific comorbidities without integrating them into a broader heart failure management context is becoming less frequent, indicating a shift towards more holistic approaches. - Generalized Risk Factors:
Articles that discuss generalized risk factors for heart failure without specific context or innovative approaches are appearing less often, as the field moves towards more targeted and individualized treatment strategies.
Similar Journals
International Journal of Cardiology
Elevating Standards in Cardiology Research and PracticeThe International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.
PROGRESS IN PEDIATRIC CARDIOLOGY
Innovating Research in Pediatric CardiologyPROGRESS IN PEDIATRIC CARDIOLOGY is a notable journal dedicated to advancing research and knowledge in the fields of pediatric cardiology and cardiovascular health in children. Published by Elsevier Ireland Ltd, this journal serves as a vital resource for clinicians, researchers, and healthcare professionals who engage with the complexities of heart diseases affecting pediatric populations. With ISSN 1058-9813 for print and 1558-1519 for online issues, it operates from Ireland and reflects a commitment to disseminating high-quality, peer-reviewed research since its inception in 1992. The journal is ranked in the Q3 category in both cardiology and pediatrics, indicating its relevance in the academic community, despite recent performance metrics showing room for growth within the competitive landscape. Researchers and practitioners can expect to find cutting-edge findings and clinical studies that aim to improve outcomes in pediatric cardiology. While it does not offer Open Access, the breadth of research covers various critical aspects, contributing significantly to the field's ongoing development.
CARDIOLOGY IN THE YOUNG
Fostering knowledge for healthier hearts in youth.CARDIOLOGY IN THE YOUNG is a premier journal published by Cambridge University Press, dedicated to the field of pediatric cardiology and cardiovascular medicine. Established in 1991, this journal has become a vital resource for researchers, clinicians, and students, focusing on the latest advancements and clinical practices related to heart conditions in children and young adults. With an ISSN of 1047-9511 and an E-ISSN of 1467-1107, it operates under a non-open access model, ensuring high-quality, peer-reviewed research is accessible to professionals in the field. The journal is recognized in the Q3 category across several disciplines, including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Pediatrics, Perinatology and Child Health, highlighting its significant academic standing within the medical community. As it converges its focus towards 2024, CARDIOLOGY IN THE YOUNG remains committed to enhancing the understanding and treatment of cardiovascular disorders, making it an essential publication for those devoted to advancing health outcomes in young populations.
Netherlands Heart Journal
Bridging Research and Practice in the World of Cardiovascular MedicineNetherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.
Journal of Cardiovascular Echography
Unveiling breakthroughs in cardiovascular echography.Journal of Cardiovascular Echography, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a premier platform for global researchers, medical professionals, and students dedicated to the ever-evolving fields of cardiology and cardiovascular imaging. With the ISSN 2211-4122 and E-ISSN 2347-193X, this journal provides access to cutting-edge research from 2011 to 2024, offering insights into the latest advancements in echocardiographic techniques and their clinical applications. Despite its current classification in the Q3 quartile within both Cardiology and Cardiovascular Medicine as well as Radiology, Nuclear Medicine, and Imaging, it continues to make meaningful contributions to the academic community, ranking 234th in the Scopus category for Radiology and 278th in Cardiology. The Journal of Cardiovascular Echography is committed to furthering knowledge and fostering collaboration among researchers by sharing critical developments in the field, making it an essential resource for anyone looking to stay abreast of transformational changes in cardiovascular diagnostics.
CARDIOLOGY CLINICS
Empowering clinicians with cutting-edge cardiology insights.CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.
HEART AND VESSELS
Bridging Research and Clinical Practice in Cardiovascular CareHEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.
Minerva Cardiology and Angiology
Exploring the frontiers of cardiology and vascular science.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
Transforming Insights into Clinical ExcellenceECHOCARDIOGRAPHY: A Journal of Cardiovascular Ultrasound and Allied Techniques is a premier scholarly publication committed to advancing the field of cardiovascular imaging through the dissemination of high-quality research and clinical studies. Published by Wiley, this journal has been a vital resource since its inception in 1984, aiming to bridge the gap between ultrasound techniques and clinical practice over its converged years extending to 2024. With an ISSN of 0742-2822 and an E-ISSN of 1540-8175, the journal is indexed in notable databases and holds a respectable standing in its field, reflected in its Q3 rankings in Cardiovascular Medicine, Miscellaneous Medicine, and Radiology for 2023. Though currently not open access, the journal strives to provide valuable insights and innovative techniques to researchers, professionals, and students alike, fostering a deeper understanding of echocardiography and its impact on patient care. Located in the United States, the journal continues to serve as a cornerstone for contemporary cardiovascular research and education, ensuring that the latest advancements and practices are readily accessible to the medical community.
Heart Failure Clinics
Elevating Standards of Care in Cardiovascular MedicineHeart Failure Clinics, published by Elsevier Science Inc, stands at the forefront of research and clinical practice in the rapidly evolving field of cardiology and cardiovascular medicine. With an ISSN of 1551-7136, this prestigious journal has established a reputation for high-quality peer-reviewed articles, offering critical insights into heart failure management, innovative therapies, and health care strategies. Ranked in the Q2 quartile for cardiology and cardiovascular medicine and recognized in the Q1 quartile for miscellaneous medicine as of 2023, it reflects a significant impact on both clinical and academic communities, holding a commendable position in the 73rd percentile of its category according to Scopus rankings. Since its inception in 2005, this journal has continuously been a vital resource for researchers, healthcare professionals, and students aiming to enhance their understanding of heart failure. Although it does not offer full open access options, the depth and relevance of its content make it indispensable for anyone engaged in heart health research and practice. Located in the heart of New York, at 230 Park Ave, STE 800, it aims to foster knowledge exchange and promote advancements in cardiovascular care until its converged years in 2024.